Zhejiang Chimin Pharm Co Ltd (603222) - Total Assets
Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) holds total assets worth CN¥2.21 Billion CNY (≈ $323.44 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang Chimin Pharm Co Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Zhejiang Chimin Pharm Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see 603222 stock market capitalisation for the company's overall valuation and market capitalisation.
Zhejiang Chimin Pharm Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Zhejiang Chimin Pharm Co Ltd's total assets of CN¥2.21 Billion consist of 25.3% current assets and 74.7% non-current assets. Review Zhejiang Chimin Pharm Co Ltd (603222) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 12.8% |
| Accounts Receivable | CN¥115.82 Million | 5.0% |
| Inventory | CN¥112.69 Million | 4.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥193.38 Million | 8.4% |
| Goodwill | CN¥14.75 Million | 0.6% |
Asset Composition Trend (2011–2025)
This chart illustrates how Zhejiang Chimin Pharm Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Zhejiang Chimin Pharm Co Ltd stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Chimin Pharm Co Ltd's current assets represent 25.3% of total assets in 2025, a decrease from 59.7% in 2011.
- Cash Position: Cash and equivalents constituted 12.8% of total assets in 2025, up from 4.7% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 14.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 8.4% of total assets.
Zhejiang Chimin Pharm Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Chimin Pharm Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0
|
Germany | €1.23 Trillion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$7.44 Billion |
|
Amplitude Surgical SAS
PA:AMPLI
|
France | €279.66 Million |
|
Suzhou Iron Technology Co. Ltd. A
SHG:688329
|
China | CN¥1.36 Billion |
|
DIO Corporation
KQ:039840
|
Korea | ₩332.33 Billion |
Zhejiang Chimin Pharm Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.94 | 1.06 | 1.18 |
| Quick Ratio | 0.79 | 0.84 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-43.86 Million | CN¥40.43 Million | CN¥133.90 Million |
Zhejiang Chimin Pharm Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Chimin Pharm Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.92 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | -4.3% |
| Total Assets | CN¥2.31 Billion |
| Market Capitalization | $635.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Chimin Pharm Co Ltd's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Zhejiang Chimin Pharm Co Ltd's assets decreased by 4.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zhejiang Chimin Pharm Co Ltd (2011–2025)
The table below shows the annual total assets of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.31 Billion ≈ $337.97 Million |
-4.34% |
| 2024-12-31 | CN¥2.41 Billion ≈ $353.30 Million |
-2.64% |
| 2023-12-31 | CN¥2.48 Billion ≈ $362.90 Million |
-8.62% |
| 2022-12-31 | CN¥2.71 Billion ≈ $397.15 Million |
+11.92% |
| 2021-12-31 | CN¥2.43 Billion ≈ $354.86 Million |
+5.81% |
| 2020-12-31 | CN¥2.29 Billion ≈ $335.39 Million |
+9.95% |
| 2019-12-31 | CN¥2.08 Billion ≈ $305.03 Million |
-1.90% |
| 2018-12-31 | CN¥2.12 Billion ≈ $310.93 Million |
+34.92% |
| 2017-12-31 | CN¥1.57 Billion ≈ $230.46 Million |
+70.74% |
| 2016-12-31 | CN¥922.43 Million ≈ $134.98 Million |
+9.29% |
| 2015-12-31 | CN¥844.01 Million ≈ $123.51 Million |
+33.96% |
| 2014-12-31 | CN¥630.04 Million ≈ $92.19 Million |
-11.68% |
| 2013-12-31 | CN¥713.38 Million ≈ $104.39 Million |
+3.29% |
| 2012-12-31 | CN¥690.63 Million ≈ $101.06 Million |
+5.39% |
| 2011-12-31 | CN¥655.30 Million ≈ $95.89 Million |
-- |
About Zhejiang Chimin Pharm Co Ltd
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture m… Read more